Literature DB >> 22162460

Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children.

G Gonzalez1, A M Davidoff, S C Howard, C-H Pui, B N Rao, J L Shenep, A Wozniak, S J Shochat.   

Abstract

BACKGROUND: Central venous catheters (CVC) facilitate the management of patients with cancer. Optimal timing for placement of a CVC is controversial. We sought to determine whether early placement in children with acute lymphoblastic leukemia (ALL), a group at high risk for infection and thrombosis, was associated with an increased rate of surgical complications. PROCEDURE: We evaluated the incidence and risk factors for early surgical complications in children with ALL diagnosed between 2004 and 2009 at a single pediatric cancer center.
RESULTS: One hundred seventy-two patients were studied. There were 17 episodes of bloodstream infection, for a 30-day incidence of 9.8% (95% CI, 5.9-15%). There were no surgical site infections and no CVC was removed due to infection. Early thrombosis occurred in only one patient, 3 days after CVC placement. Infection was not influenced by catheter type, patient age, body mass index, or fever at the time of placement. The infection rate was not statistically higher when the ANC was <500/mm(3) at the time of CVC placement (14.2% vs. 6.8%; P = 0.12).
CONCLUSION: Early CVC placement at the time of diagnosis of ALL was associated with a low surgical complication rate with no catheters requiring removal due to infection. Utilizing our current methods of preoperative preparation, surgical management and postoperative CVC care, early placement of a CVC is safe in children with ALL even when their ANC is <500/mm(3) , but larger cohort studies would be helpful to further clarify this issue.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22162460      PMCID: PMC4666499          DOI: 10.1002/pbc.24010

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  22 in total

1.  Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.

Authors:  S Revel-Vilk; J Yacobovich; H Tamary; G Goldstein; S Nemet; M Weintraub; O Paltiel; G Kenet
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

Review 2.  Management of venous port systems in oncology: a review of current evidence.

Authors:  S Vescia; A K Baumgärtner; V R Jacobs; M Kiechle-Bahat; A Rody; S Loibl; N Harbeck
Journal:  Ann Oncol       Date:  2007-09-09       Impact factor: 32.976

3.  Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin.

Authors:  P Vaudaux; D Pittet; A Haeberli; E Huggler; U E Nydegger; D P Lew; F A Waldvogel
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

4.  Differential quantitation with a commercial blood culture tube for diagnosis of catheter-related infection.

Authors:  P M Flynn; J L Shenep; F F Barrett
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

5.  Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters.

Authors:  A C Molinari; E Castagnola; C Mazzola; M Piacentino; G Fratino
Journal:  Support Care Cancer       Date:  2001-10       Impact factor: 3.603

6.  Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.

Authors:  Mette Møller Handrup; Jens Kjølseth Møller; Morten Frydenberg; Henrik Schrøder
Journal:  Pediatr Blood Cancer       Date:  2010-08       Impact factor: 3.167

7.  Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices.

Authors:  G Fratino; A C Molinari; S Parodi; S Longo; P Saracco; E Castagnola; R Haupt
Journal:  Ann Oncol       Date:  2005-01-27       Impact factor: 32.976

8.  Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices.

Authors:  Leon J Worth; John F Seymour; Monica A Slavin
Journal:  Support Care Cancer       Date:  2008-12-19       Impact factor: 3.603

9.  A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.

Authors:  Lesley G Mitchell; Maureen Andrew; Kim Hanna; Thomas Abshire; Jacqueline Halton; Ron Anderson; Irene Cherrick; Sunil Desai; Donald Mahoney; Patricia McCuster; John Wu; Gary Dahl; Peter Chait; Gabrielle de Veber; Kyong-Jin Lee; David Mikulis; Jeffrey Ginsberg; Cliford Way
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

10.  Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.

Authors:  Panagiotis Samaras; Stefan Dold; Julia Braun; Peter Kestenholz; Stefan Breitenstein; Alexander Imhof; Christoph Renner; Frank Stenner-Liewen; Bernhard C Pestalozzi
Journal:  Oncology       Date:  2008-08-21       Impact factor: 2.935

View more
  3 in total

1.  Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.

Authors:  Natalie K Bradford; Rachel M Edwards; Raymond J Chan
Journal:  Cochrane Database Syst Rev       Date:  2020-04-30

2.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

3.  Impact of Perioperative Absolute Neutrophil Count on Central Line-Associated Bloodstream Infection in Children With Acute Lymphoblastic and Myeloid Leukemia.

Authors:  Illya Martynov; Joachim Schoenberger
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.